NeoGenomics Laboratories

Fort Myers, FL
United States
http://www.neogenomics.com

Booth: 18103

NeoGenomics specializes in cancer genetics testing and information services, providing comprehensive oncology-focused testing menus to help physicians diagnose and treat cancer with >650 tests including flow cytometry, FISH, cytogenetics, and targeted or broad-panel DNA- and RNA-based NGS. Our Pharma Services Division serves pharmaceutical clients in clinical trials and drug development from biomarker discovery through CDx validation and commercialization. RaDaR(TM) is our liquid biopsy focused subsidiary Inivata’s multi-tumor assay for the detection of residual disease and recurrence.

Products

NeoTYPE® DNA & RNA - Lung

Streamlined NGS tumor profile maximizes yield by analyzing DNA and RNA in a single test.... More Info Less Info

This streamlined NGS tumor profile maximizes yield by analyzing DNA and RNA in a single test to detect SNV/indels, CNVs, and/or RNA Fusions in 50 genes, plus MSI and TMB. PD-L1 is available. Results inform of therapy options, prognostic implications, and clinical trial opportunities.

RaDaR™

RaDaR™ is a highly sensitive, personalized minimal residual disease (MRD) and recurrence assay for solid tumor cancers.... More Info Less Info

RaDaR™ is a highly sensitive, personalized minimal residual disease (MRD) and recurrence assay for solid tumor cancers. Built on the InVision® platform, RaDaR™ has been granted Breakthrough Device Designation by the FDA. After initial test design, blood ctDNA results are available in 7 days.

Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?

Yes

NeoGenomics Laboratories

Products

Additional Info

Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?

Categories

Contact this Exhibitor